NCT00446056View on ClinicalTrials.gov

Montelukast Post-Marketing Comparative Study With Ketotifen (0476-379)

PHASE4CompletedINTERVENTIONAL
Enrollment

188

Participants

Timeline

Start Date

September 25, 2003

Primary Completion Date

June 16, 2004

Study Completion Date

June 16, 2004

Conditions
Asthma
Interventions
DRUG

MK0476, montelukast sodium / Duration of Treatment: 4 Weeks

DRUG

Comparator: ketotifen / Duration of Treatment: 4 Weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00446056 - Montelukast Post-Marketing Comparative Study With Ketotifen (0476-379) | Biotech Hunter | Biotech Hunter